Kristina Burow - Sep 14, 2023 Form 4 Insider Report for Neumora Therapeutics, Inc. (NMRA)

Role
Director
Signature
/s/ Joshua Pinto, as Attorney-in-Fact for Kristina M. Burow
Stock symbol
NMRA
Transactions as of
Sep 14, 2023
Transactions value $
$0
Form type
4
Date filed
9/18/2023, 05:54 PM
Previous filing
Jun 23, 2023
Next filing
Sep 20, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NMRA Stock Option (Right to Buy) Award $0 +46.5K $0.00 46.5K Sep 14, 2023 Common Stock 46.5K $17.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/36th of the shares subject to the option vest on each monthly anniversary measured from September 14, 2023 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Vesting Commencement Date.